LATEST
-
- Opinion
Big Pharma Resistance to Trump’s Push for Most Favored Nation Status Is Starting to Crack
J.D. HayworthFor years, Big Pharma stood together, warning that President Donald Trump’s “Most-Favored-Nation” executive order would stifle innovation and that the policy is “irresponsible and unworkable.” Trump’s Most-Favored-Nation policy is simple: If Americans are paying more for the same medicine than patients overseas, drug companies must lower their prices here to match the lowest price abroad….

Don’t miss the

